Healthcare entity
All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention AtaiBeckley, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Beckley Psytech, all published on March 8, 2026.
Last mentioned: Mar 8, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention AtaiBeckley, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Beckley Psytech, all published on March 8, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 15 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Beckley Psytech. Shared-story counts are live from our verified record — not editorial picks.
Phase 3 Initiation
Expected launch of the global Phase 3 program for BPL-003 in TRD.
Results Announcement
Company reports 2025 results and confirms Phase 3 timeline.
Fiscal Year End
AtaiBeckley completes 2025 with focused R&D spending on lead assets.
Strategic Investment
atai Life Sciences invests $50M in Beckley Psytech to accelerate BPL-003.
AtaiBeckley has announced its 2025 financial results, highlighted by the upcoming Q2 2026 Phase 3 trial launch for its lead candidate, BPL-003. The intranasal 5-MeO-DMT compound is positioned as a potential blockbuster for treatment-resistant depression with a significantly shorter clinical footprint than existing therapies.
Source: finance.yahoo.com · insidermonkey.com
Beckley Psytech is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
